NEW YORK--(BUSINESS WIRE)--MSMB Capital Management today announced that it has filed an amended preliminary Consent Solicitation Statement with the Securities and Exchange Commission that seeks, among other things, to remove each of the current directors of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and replace them with MSMB's nominees. MSMB amended its filing to increase the number of nominees to include Richard B. Brewer and David Gryska, each of whom have extensive management experience in the healthcare industry.